Opioids in chronic pain

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 79-91

  Przewlocki, Ryszard ^a   Przewlocka, Barbara ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Endomorphin; Inflammation; Neuropathic pain; Nociceptin; Opioid; Opioid receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA ENDORPHIN; BETA FUNALTREXAMINE; CYPRODIME; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DIZOCILPINE; DYNORPHIN; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONAZINE; NALOXONE; NOCICEPTIN; OPIATE; OPIATE RECEPTOR; PRODYNORPHIN; PROENKEPHALIN; PROOPIOMELANOCORTIN; RECEPTOR SUBTYPE; UNINDEXED DRUG;

ANALGESIA; ANTINOCICEPTION; APPETITE; BIOGENESIS; BIOSYNTHESIS; BRAIN REGION; CHRONIC ARTHRITIS; CHRONIC PAIN; DRUG EFFICACY; DRUG POTENCY; GENE EXPRESSION; HUMAN; INFLAMMATION; LEARNING; LOCOMOTION; NEUROPATHY; NOCICEPTIVE STIMULATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY;

ANIMALS; CHRONIC DISEASE; HUMANS; NARCOTICS; OPIOID PEPTIDES; PAIN; RECEPTORS, OPIOID;

EID: 0035840823     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01308-5     Document Type: Review

References (145)

1. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: Evidence for region-specific processing
2. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation
3. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
4. Nitric oxide-induced headache in patients with chronic tension-type headache
5. Opposite motivational effects of endogenous opioids in brain and periphery
6. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats
7. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury
8. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: Restoration by MK-801 or dynorphin antiserum
9. Peptide hormones shared by the neuroendocrine and immunologic systems
10. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: Detection of POMC mRNA
11. Comparative study of the neuronal populations containing beta-endorphin, corticotropin and dopamine in the arcuate nucleus of the rat hypothalamus
12. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I
13. Evidence for a delta-class opioid receptor on cells of the immune system
14. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat
15. Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats
16. + channel
17. Molecular cloning and functional expression of a mu-opioid receptor from rat brain
18. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors
19. Mu opioid receptor gene expression in immune cells
20. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats
21. Endomorphins and activation of the hypothalamo-pituitary-adrenal axis
22. Lack of significant changes in mu, delta opioid binding sites and neutral endopeptidase EC 3.4.24.11 in the brain and spinal cord of arthritic rats
23. Activity-dependent neuronal plasticity following tissue injury and inflammation
24. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test
25. Cloning of a delta opioid receptor by functional expression
26. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action
27. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury
28. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury
29. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia
30. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes
31. Identification of kappa- and delta-opioid receptor transcripts in immune cells
32. Reorganization of the spinal dorsal horn in models of chronic pain: Correlation with behaviour
33. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain
34. The effect of intrathecal endomorphin-2 on the flexor reflex in normal, inflamed and axotomized rats: Reduced effect in rats with autotomy
35. Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered nitric oxide synthase inhibitors
36. Contrasting actions of intrathecal U50,488H, morphine, or [d-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat
37. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat
38. Opioids and opioid receptors in peripheral tissues
39. Role of immune processes in peripheral opioid analgesia
40. Peripheral opioid analgesia - Facts and mechanisms
41. Regulation of opioid peptides gene expression
42. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms
43. Increased spinal cord dynorphin mRNA during peripheral inflammation
44. Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation
45. G-protein-coupled receptor heterodimerization modulates receptor function
46. Cloning and sequence analysis of cDNA for porcine beta-neoendorphin/dynorphin precursor
47. Anatomy of CNS opioid systems
48. The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
49. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization
50. Spinally administered dynorphin A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors
51. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model
52. Molecular cloning and expression of a rat kappa opioid receptor
53. Morphological characterization of marginal (lamina I) neurons immunoreactive for substance P, enkephalin, dynorphin and gamma-aminobutyric acid in the rat spinal cord
54. Pain control by immune-derived opioids
55. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord
56. Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord
57. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice
58. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats
59. Immunohistochemical localization of neuropeptides and neurotransmitters in the nucleus solitarius
60. Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
61. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers
62. Spinal opioid delta antinociception in the mouse: Mediation by a 5′-NTII-sensitive delta receptor subtype
63. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions
64. Nitric oxide (NO) and nociceptive processing in the spinal cord
65. Cloning and pharmacological characterization of a rat kappa opioid receptor
66. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
67. The role of delta-opioid receptor subtypes in neuropathic pain
68. Cloning and expression of a cDNA for the rat kappa-opioid receptor
69. Topographical requirements for delta opioid ligands: Presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity
70. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing
71. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor
72. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands
73. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor
74. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin
75. Preproenkephalin gene expression in the rat spinal cord after noxious stimuli
76. Nocistatin, a peptide that blocks nociceptin action in pain transmission
77. Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: Isobolographic analysis
78. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat
79. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
80. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat
81. Antisense mapping: Assessing functional significance of genes and splice variants
82. The opioid-cytokine connection
83. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: Implication of an atypical mu-opioid receptor
84. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey
85. Central beta-endorphin system involvement in the reaction to acute tonic pain
86. Breakthrough pain: Definition, prevalence and characteristics
87. The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions
88. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats
89. Time-dependent changes in the activity of opioid systems in the spinal cord of monoarthritic rats - A release and in situ hybridization study
90. Intrathecal oxotremorine affects formalin-induced behavior and spinal nitric oxide synthase immunoreactivity in rats
91. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats
92. Mixed opioid/nonopioid effects of dynorphin and dynorphin-related peptides after their intrathecal injection in rats
93. Opioid peptides, particularly dynorphin and chronic pain
94. The influence of chronic stress on multiple opioid peptide systems in the rat: Pronounced effects upon dynorphin in spinal cord
95. Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat
96. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception
97. Inhibition of nitric oxide synthase enhances morphine antinociception in the spinal cord
98. Pain inhibition by endomorphins
99. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor
100. Is agmatine a novel neurotransmitter in brain?
101. Nociceptin, endomorphin-1 and -2 do not interact with invertebrate immune and neural mu 3 opiate receptor
102. Effects of sciatic nerve injuries on delta-opioid receptor and substance P immunoreactivities in the superficial dorsal horn of the rat
103. The enkefalinase inhibitor thiorphan shows antinociceptive activity in mice
104. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia
105. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia
106. Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes
107. Synthesis and biological evaluation of 14-alkoxymorphinans. 2.1(-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective μ opioid receptor antagonist
108. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions
109. Opioid peptides and opioid receptors in cells of the immune system
110. Alterations in rat spinal cord cGMP by peripheral nerve injury and adrenal medullary transplantation
111. Immunoreactive beta-endorphin and ACTH in the same neurons of the hypothalamic arcuate nucleus in the rat
112. Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice
113. Unilateral hindpaw inflammation produces a bilateral increase in NADPH-diaphorase histochemical staining in the rat lumbar spinal cord
114. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation
115. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation
116. Dynorphin A and related peptides administered intrathecally in the rat: A search for putative kappa opiate receptor activity
117. Evidence for delta opioid receptor subtypes in rat spinal cord: Studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2 Glu4]deltorphin
118. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2
119. A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy
120. Nociceptin/orphanin FQ. A new opioid, a new analgesic?
121. Cloning and pharmacological characterization of a rat mu opioid receptor
122. Cerebrospinal fluid levels of beta endorphin in painful and painless diabetic polyneuropathy
123. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene
124. The mu opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responses
125. Opiate-like materials in the adrenal medulla: Evidence for storage and secretion with catecholamines
126. Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats
127. Nonopiate effects of dynorphin and des-Tyr-dynorphin
128. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors
129. Pronociceptive actions of dynorphin maintain chronic neuropathic pain
130. Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies
131. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats
132. Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats
133. Central and systemic morphine-induced antinociception in mice: Contribution of descending serotonergic and noradrenergic pathways
134. Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord
135. Dissociation of analgesic and rewarding effects of endomorphin-1 in rats
136. Tissue distribution of opioid receptor gene expression in the rat
137. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes
138. Effects of intrathecally administered nociceptin, an opioid receptor-like 1 receptor agonist, and N-methyl-D-aspartate receptor antagonists on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat
139. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat
140. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like 1 receptor agonist, in the rat formalin test
141. Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carageenan injection into the rat paw
142. Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat
143. A potent and selective endogenous agonist for the μ-opiate receptor
144. Endomorphins: Novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density
145. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy